J Korean Med Sci.  2023 Mar;38(11):e100. 10.3346/jkms.2023.38.e100.

The Crucial Role of COVID-19 Vaccination in Preventing Severe Illness and Death: Evidence From a Korean Perspective

• Jung J

• KMID: 2540648
• DOI: http://doi.org/10.3346/jkms.2023.38.e100

Figure

• 

  Fig. 1 Daily new COVID-19 cases, deaths (7-day rolling average) and cumulative COVID-19 vaccination doses administered per 100 people. Note that vaccination doses administered per 100 people is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime. Data available at: kdca.go.kr.

Reference

1. Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, et al. Estimated effectiveness of COVID-19 vaccines against omicron or delta symptomatic infection and severe outcomes. JAMA Netw Open. 2022; 5(9):e2232760. PMID: 36136332.

2. Tseng HF, Ackerson BK, Bruxvoort KJ, Sy LS, Tubert JE, Lee GS, et al. Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nat Commun. 2023; 14(1):189. PMID: 36635284.

3. Kim YY, Choe YJ, Kim J, Kim RK, Jang EJ, Lee H, et al. Vaccine effectiveness against severe disease and death for patients with COVID-19 during the delta-dominant and omicron-emerging periods: a K-COVE study. J Korean Med Sci. 2023; 38(11):e87.

4. Nham E, Song JY, Noh JY, Cheong HJ, Kim WJ. COVID-19 vaccination in Korea: past, present, and the way forward. J Korean Med Sci. 2022; 37(47):e351. PMID: 36472087.

5. KDCA. Opening big data for effective response to COVID-19. Updated 2022. Accessed February 25, 2023. https://www.kdca.go.kr/board/board.es?mid=a20501010000&bid=0015&list_no=719138&cg_code=&act=view&nPage=2 .